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A Rare Presentation of Fulminant Toxic Shock Syndrome in a Healthy 10-Year-Old
Male Patient
Abstract
Staphylococcal toxic shock syndrome (STSS) is characterized by acute, progressive illness with fever,
rapid-onset hypotension, and multisystem organ failure. The clinical course of STSS is attributable to host
response to exotoxins with superantigenic properties. Fulminant staphylococcal infection is often
associated with a deep focus of infection. In this report, we present a 10-year-old boy with multisystem
organ failure as a result of STSS, a rare fatal complication following soft tissue injury. The rapid and
fulminant progression of the disease in our patient precluded early timely diagnosis of STSS that may
have allowed for the initiation of life-saving supportive intervention. Furthermore, the rapidly developing
STSS occurred without an identifiable infectious source. The diagnosis of STSS was made upon the sum
total of the clinical presentation, laboratory and autopsy findings, and antemortem and postmortem
microbiology studies. It is crucial for health care providers to be aware of the possibility of STSS, even in
the absence of overt focal infections and risk factors. A high index of suspicion for STSS should be
present in critically ill patients presenting with a precipitous course of sepsis, septic shock, or systemic
inflammatory response syndrome (SIRS).
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CASE REPORT

A Rare Presentation of Fulminant Toxic Shock
Syndrome in a Healthy 10-Year-Old Male Patient
Albert Sabirov a,*, Michael Caplan a,b
a
b

Lake Erie College of Osteopathic Medicine, USA
Franklin County Forensic Science Center/Ofﬁce of the Coroner, USA

Abstract
Staphylococcal toxic shock syndrome (STSS) is characterized by acute, progressive illness with fever, rapid-onset
hypotension, and multisystem organ failure. The clinical course of STSS is attributable to host response to exotoxins
with superantigenic properties. Fulminant staphylococcal infection is often associated with a deep focus of infection. In
this report, we present a 10-year-old boy with multisystem organ failure as a result of STSS, a rare fatal complication
following soft tissue injury. The rapid and fulminant progression of the disease in our patient precluded early timely
diagnosis of STSS that may have allowed for the initiation of life-saving supportive intervention. Furthermore, the
rapidly developing STSS occurred without an identiﬁable infectious source. The diagnosis of STSS was made upon the
sum total of the clinical presentation, laboratory and autopsy ﬁndings, and antemortem and postmortem microbiology
studies. It is crucial for health care providers to be aware of the possibility of STSS, even in the absence of overt focal
infections and risk factors. A high index of suspicion for STSS should be present in critically ill patients presenting with
a precipitous course of sepsis, septic shock, or systemic inﬂammatory response syndrome (SIRS).
Keywords: Staphylococcal, Toxic shock syndrome

1. Introduction

T

oxic shock syndrome is a superantigen-mediated disease caused by Staphylococcus aureus
(S. aureus) and Streptococcus pyogenes. The characteristics of toxic shock syndrome include an acute,
progressive illness associated with fever, rapid-onset
hypotension, and precipitous multisystem failure.
Staphylococcal toxic shock syndrome (STSS) may
result from any staphylococcal infection, mucosal
colonization, in association with abscesses or burns,
and following surgical procedures.1 Risk factors for
STTS include absence of protective antitoxin antibodies, aplastic anemia, diabetes, chronic hepatitis C,
cancer, human immunodeﬁciency virus infection or
the acquired immunodeﬁciency syndrome, and injection-drug use.2e4
The Center for Disease Control provides several
criteria for the diagnosis of STSS, that divide the

diagnosis of STSS into probable and conﬁrmed by
using a multimodal approach (Table 1).5
The early diagnosis of STSS is important to target
the treatment for S. aureus toxin-mediated disease,
including supportive management, antimicrobial
therapy, intravenous immunoglobulins (IVIG), and
corticosteroids.6 We describe the case of an otherwise
healthy patient without a known source of infection
or predisposing risk factors who succumbed to
fulminant STSS.

2. Case Presentation
A 10-year-old Caucasian male with a known history
of congenital left-sided ureterovesical obstruction
was transported to a community hospital in cardiac
arrest. The patient began to complain of left hip and
groin pain following football practice, two days prior
to admission. On the day before admission, he stayed
home from school secondary to continued hip pain,
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Table 1. Staphylococcal toxic shock syndrome.
Clinical Criteria
An illness with the following clinical manifestations:
 Fever: temperature greater than or equal to 102.0  F (greater than or equal to 38.9  C)
 Rash: diffuse macular erythroderma
 Desquamation: 1e2 weeks after onset of rash
 Hypotension: systolic blood pressure less than or equal to 90 mm Hg for adults or less than ﬁfth percentile by age for children
aged less than 16 years
 Multisystem involvement (three or more of the following organ systems):
B
B
B
B
B
B
B

Gastrointestinal: vomiting or diarrhea at onset of illness
Muscular: severe myalgia or creatine phosphokinase level at least twice the upper limit of normal
Mucous membrane: vaginal, oropharyngeal, or conjunctival hyperemia
Renal: blood urea nitrogen or creatinine at least twice the upper limit of normal for laboratory or urinary sediment with
pyuria (greater than or equal to 5 leukocytes per high-power ﬁeld) in the absence of urinary tract infection
Hepatic: total bilirubin, alanine aminotransferase enzyme, or asparate aminotransferase enzyme levels at least twice the
upper limit of normal for laboratory
Hematologic: platelets less than 100,000/mm3
Central nervous system: disorientation or alterations in consciousness without focal neurologic signs when fever and
hypotension are absent

Laboratory Criteria for Diagnosis
Negative results on the following tests, if obtained:
 Blood or cerebrospinal ﬂuid cultures (blood culture may be positive for Staphylococcus aureus)
 Negative serologies for Rocky Mountain spotted fever, leptospirosis, or measles
Case Classiﬁcation
Probable
A case which meets the laboratory criteria and in which four of the ﬁve clinical criteria described above are present
Conﬁrmed
A case which meets the laboratory criteria and in which all ﬁve of the clinical criteria described above are present, including
desquamation, unless the patient dies before desquamation occurs
The table has been adapted from Toxic Shock Syndrome (Other Than Streptococcal) (TSS) 2011 Case Deﬁnition.5

which was treated with ibuprofen. On the day of
admission, the patient began to experience vomiting,
diarrhea, and fever to 39.4  C, followed by disorientation and abnormal movements suggestive of
seizure activity. Shortly after, he collapsed, followed
by apnea and pulselessness, ventricular ﬁbrillation,
evolving to pulseless electrical activity (PEA), which
was treated with Pediatric Advanced Life Support
(PALS) protocol, with return of spontaneous circulation (ROSC). The total time of cardiopulmonary
resuscitation (CPR) was estimated at 20e30 min. In
the Emergency Department of the community
hospital he was started on vancomycin and ceftriaxone for a suspected possible infectious etiology,
and intravenous ﬂuids were administered for volume
support. Norepinephrine and bicarbonate drips were
given for profound hypotension and metabolic
acidosis. On admission, his recorded vital signs
included a blood pressure in the 60s/20s (mmHg) and
a rectal temperature of 39.9  C. Pertinent ﬁndings on
physical examination included cool extremities with
faint central and peripheral pulses, a distinctly prolonged capillary reﬁll time of ~10 s, and mottled skin
surfaces, signs all indicative of poor perfusion. Cardiac and pulmonary examinations revealed normal
S1 and S2 heart sounds without murmurs and lungs
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that were clear to auscultation bilaterally, although
pitting edema was noted in the lower legs. EKG
showed normal sinus rhythm with a rate of 94 bpm.
The patient's chest x-ray did not show focal consolidation or a pleural effusion. Arterial blood gas (ABG)
analysis was performed and revealed a pH of 6.83,
HCO3- of 7 mmol/L, pCO2 of 41 mmHg, and base
excess of 28.2 mmol/L, indicative of a pronounced
metabolic acidosis. He was then transferred to the
PICU for further management. He developed renal
failure with laboratory features of azotemia (BUN:
37 mg/dL; reference range [RR]: 7e17 mg/dL and
creatinine: 4.11 mg/dL [RR: 0.23e0.61 mg/dL]). That
deteriorated to anuria with no urine output. Additional noteworthy metabolic derangements included
marked hypocalcemia and hyperphosphatemia
(serum calcium: 4.7 mg/dL [RR: 8.9e10.1 mg/dL] and
phosphorous: 11.4 mg/dL [RR: 3.78e6.47 mg/dL]). As
the patient exhibited combined features of refractory
hypotension, signs of poor perfusion concerning for
poor cardiac output, and absence of urine output on
presentation, he was deemed to be in critical condition with a grave prognosis. Over the next several
hours, despite increasing doses of epinephrine and
norepinephrine, as well as crystalloid and colloid
infusions, the patient's blood pressure continued to
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Table 2. Laboratory workup.
Blood Test

Result

Reference Value

pH, Arterial
pCO2
pO2
HCO3, Arterial
Base Excess, Arterial
O2 Sat, Arterial
Sodium
Potassium
Chloride
Bicarbonate
Glucose
BUN
Creatinine
Anion Gap
Calcium
Phosphorus
Magnesium
WBC
Neutrophils, Absolute
RBC
Hemoglobin
Hematocrit
Platelets
Prothrombin Time
Prothrombin Time, INR
aPTT

<6.827
41 mmHg
402 mmHg
4.2 mmol/L
28.2 mmol/L
97.3%
133 mmol/L
5.9 mmol/L
102 mmol/L
7 mmol/L
180 mg/dL
37 mg/dL
4.11 mg/dL
24 mmol/L
4.7 mg/dL
11.4 mg/dL
3.0 mg/dL
4.78 K/uL
1.39 K/uL
3.80 M/uL
10.9 g/dL
33.4%
57 K/uL
40.1 s
3.5
68.5 s

7.38e7.46
32e46 mmHg
74e108 mmHg
21.0e29.0 mmol/L
-2-þ2 mmol/L
92e96%
134e143 mmol/L
3.4e4.7 mmol/L
96e109 mmol/L
21e31 mmol/L
74e118 mg/dL
7e17 mg/dL
0.23e0.61 mg/dL
9e16 mmol/L
8.9e10.1 mg/dL
3.78e6.47 mg/dL
1.6e2.2 mg/dL
5.7e10.5 K/uL
1.8e5.4 K/uL
3.9e5.0 M/uL
11.1e14.5 g/dL
32.9e21.5
150e400 K/uL
11.5e13.5 s
0.8e1.2
27e38 s

fall. Because the patient's clinical presentation
prompted the consideration of an infectious etiology
with resultant septic shock, a workup including blood
culture and parameters for disseminated intravascular coagulation (DIC) was initiated, with elevated
prothrombin time (PT: 40.1 s; RR: 11.5e13.5 s; INR:
3.5) and activated partial thromboplastin time (aPTT:
68.5 s; RR: 27e38 s) and thrombocytopenia (platelet
count: 57 K/uL: RR: 150e400 K/uL). Various laboratory parameters are summarized in Table 2. Blood
cultures and PCR assay were submitted for microbial
culture and viral respiratory pathogen panel,
including SARS-CoV-2 (Table 3). Approximately
9 hours after admission, in light of the patient's poor
prognosis, all medications were discontinued and the
patient was pronounced dead. The death was reported to and accepted for jurisdiction by the County
Medical Examiner's Ofﬁce, based upon criteria of
both a sudden unexplained death and the consideration of a transmissible communicable infection that
carried potential public health implications.
At autopsy, no source of infection, including the
site of the initial trauma, was identiﬁed. Autopsy
revealed widespread mucosal and serosal hemorrhages (Figs. 1 and 2), as well as petechiae of the skin,
palpebral conjunctivae, and epicardial and visceral
pleural surfaces; these ﬁndings are characteristic of
the hemorrhagic diathesis of disseminated
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intravascular coagulation (DIC) that manifests
following the consumption of platelets and therefore
reﬂect profound derangements in primary hemostasis. Other gross autopsy ﬁndings included
swelling of the face and scalp, bilateral serosanguineous pleural effusions, serous ascites, slight brain
swelling, pulmonary edema, and congestive
splenomegaly. The presence of the left megaureter
(left ureter width: ~1 cm and right ureter width:
~0.4 cm) with slight calyceal dilatation of the left
kidney (left hydronephrosis; Fig. 3) conﬁrmed the
clinically documented congenital obstruction of left
ureterovesical junction. The most notable microscopic autopsy ﬁndings were intracapillary ﬁbrin
thrombi, which were seen within the adrenal glands,
kidneys, skin, and mesenteric lymph nodes. Additional distinctive microscopic ﬁndings consisted of
adrenal cortical hemorrhages, marked hemophagocytosis within vertebral bone marrow, and acute
cholangitis with mixed inﬂammation and edema of
portal tracts. These ﬁndings were similar to those
described in sepsis-related death.7 Postmortem
toxicology was negative for illicit drugs.
In an attempt to elucidate an infectious etiology
and source for the child's abrupt downward clinical
course, additional microbiologic investigations were
pursued and samples submitted, including PCR for
identiﬁcation of S. aureus virulence factors and respiratory pathogen panel, aerobic and stool cultures.
Conﬁrmatory antemortem and postmortem microbiology laboratory ﬁndings are summarized in
Table 2 and include the following: a) isolation of S.
aureus from antemortem blood, b) postmortem
isolation of S. aureus from multiple organs and cerebrospinal ﬂuid, c) detection of S. aureus virulence
factors, including toxic shock syndrome toxin-1
(TSST-1) and S. aureus enterotoxin A (SEA) DNA by
real-time polymerase chain reaction (PCR).
Based upon the sum total of the decedent's clinical
presentation, and laboratory ﬁndings, autopsy ﬁndings, and antemortem and postmortem microbiology
studies, including cultures and molecular methods
for S. aureus virulence factors and toxins, the cause of
death in this 10-year-old boy was certiﬁed as multisystem organ failure as a result of a rare fatal
complication S. aureus infection, namely STSS.

3. Discussion
STSS is caused by a host response to superantigens from S. aureus, which are proteins capable
of directly activating T-lymphocytes by bypassing
certain steps of the antigen-mediated immune
response
sequence,
namely,
the
normal
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Table 3. Antemortem and postmortem microbiology ﬁndings.
Antemortem Microbiology
Laboratory Findings

Result

Reference value

SARS-CoV-2 PCR
Blood Culture

Not Detected
Growth of S. aureusa

Negative
No growth

Postmortem Microbiology
Laboratory Findings

Result

Reference value

Detected
Not Detected
Not Detected
Detected
Not Detected
Not Detected
Detected
Not Detected
Not Detected
Not Detected
Not Detected
Not Detected

Not
Not
Not
Not
Not
Not
Not
Not
Not
Not
Not
Not

Postmortem Microbiology
Laboratory Findings

Result

Reference Value

Blood Culture (heart blood)
Respiratory Pathogen Panel RNA PCRc:
Inﬂuenza Type A
Inﬂuenza Type B
Respiratory Syncytial Virus
Human Metapneumovirus
Aerobic Cultures:
CSF
Right and left lungs
Liver
Spleen
Fascia Lata
Stool Culture:
Colon

No growth

No growth

Negative
Negative
Negative
Negative

Negative
Negative
Negative
Negative

S. aureus
S. aureus
S. aureus
S. aureus
No growth

No
No
No
No
No

No growth

Normal enteric ﬂora

S. aureus Virulence Factors DNA PCR b:
S. aureus DNA
mecA gene DNA
Panton-Valentine leukocidin (PVL) DNA
Toxic shock syndrome toxin-1 DNA
Exfoliative toxin A DNA
Exfoliative toxin B DNA
S. aureus enterotoxin A DNA
S. aureus enterotoxin B DNA
S. aureus enterotoxin C DNA
S. aureus enterotoxin D DNA
S. aureus enterotoxin E DNA
S. aureus Toxic Shock
Syndrome Toxin

a
b
c

Detected
Detected
Detected
Detected
Detected
Detected
Detected
Detected
Detected
Detected
Detected
Detected

growth
growth
growth
growth
growth

Staphylococcus aureus.
Blood.
Nasopharyngeal.

histocompatibility complex (MHC)-restricted antigen speciﬁcity. When this process occurs, it can
activate up to 30% of total T-lymphocytes, thereby
precipitating an explosive release of cell mediators
known as cytokines, which amplify the immune
response by recruiting and further activating additional T- and B-lymphocytes.8 The majority of cases
of STSS are due to the four exotoxins with superantigenic properties: TSST-1, SEA, SEC, and SEB.9
SEA has been speciﬁcally associated with septic
shock in the course of bacteremia.10
In the present case, despite presumptive treatment
for bacterial infections with broad-spectrum antibiotics, the child was not able to overcome the effects of
the S. aureus-produced exotoxins with superantigenic properties. This is a rare case of fulminant
STSS without an identiﬁable source of infection. TSS
can occasionally occur without an established source
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of infection; however, fulminant staphylococcal
infection is often associated with a deep focus of
infection, including necrotizing pneumonia, necrotizing fasciitis, and infective endocarditis.1,11
In the present case, the most likely source of
infection appears to be a soft tissue injury, given the
temporal relationship of the onset of left lower extremity pain with a recent football practice, although
this cannot be proven with certainty. It is also
possible that obstruction of ureterovesical junction
facilitated the subclinical mucosal colonization of S.
aureus within the left megaureter, and that soft tissue injury caused mucous membrane breakdown in
the susceptible host (i.e., insufﬁcient antibody to S.
aureus produced exotoxins). In our patient, a urine
sample could not be obtained for microbiological
culture due to anuria following acute kidney failure.
An additional consideration was that the patient was
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Fig. 1. The serosal surfaces of loops of small intestine are studded with
numerous ﬁne petechiae, some of which are focally conﬂuent and
appear “purpuric”.

treated with ibuprofen at home. The link between
the use of nonsteroidal anti-inﬂammatory drugs
(NSAID) and the development of STSS has been
reported.12 Speciﬁcally, NSAIDs can enhance production of cytokines and impair granulocytes
production.
It was suggested that the toxigenic strain of S. aureus
may originate from the patient's own site of colonization rather than infection, especially, after disruption
of the skin or mucous membrane or after surgery.2,13
Asymptomatic carriage of TSST-1-producing S. aureus
was demonstrated in genital and nasal mucosa.14,15
Factors that trigger the transformation of asymptomatic colonization or infection with a toxin-producing
strain of S. aureus into TSS are poorly understood. One
possible explanation for the development of TSS is the
inability of the host to acquire antibodies to TSST-1

Fig. 3. Both kidneys are displayed in their in situ conﬁguration to
highlight asymmetrical dilatation of the left ureter (megaureter; left
ureter width: ~1 cm; right ureter width: ~0.4 cm) due to congenital left
ureteropelvic obstruction.

due to genetic predisposition or age-related differences.8 Individuals aged <20 years were shown to
have lower titers or absence of antibodies to TSST-1 as
compared with older individuals.8,15,16
The present case presented several challenges.
Firstly, the rapid progression of the disease in our
patient precluded early diagnosis of STSS. Our patient
did not exhibit all of the signs and symptoms required
to satisfy the complete clinical criteria established by
the Centers for Disease Control and Prevention (CDC)
for the probable or conﬁrmed diagnosis of STSS. This
patient met only four out of six criteria, including fever
>39.9  C, hypotension with SBP 5th percentile in <16
years old, multi-organ involvement, and blood cultures positive for S. aureus.11 However, many of these
criteria develop later in the course of the disease and
should not be used for diagnosis in the acute settings.6
For example, skin desquamation occurs within 1e2
weeks after the appearance of the generalized cutaneous rash. In addition, the presence of S. aureus DNA
and S. aureus secreted toxins (TSST-1 and SEA) DNA
by real-time PCR in an isolate obtained from the
decedent's blood was not conﬁrmed until day 15
postmortem. Secondly, the rapid development and
fulminant course of STSS occurred without an identiﬁable infectious source.

4. Conclusion

Fig. 2. Numerous petechiae, some of which are focally conﬂuent,
decorate the costal visceral pleural surface of the left lung.
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It is crucial for health care providers to be aware
of the possibility of STSS, even in the absence of
overt focal infections and risk factors. In critically ill
patients with a fulminant course of sepsis or septic
shock, there should be a high index of suspicion for
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STSS, Moreover, further research into discovering
new diagnostic techniques for earlier detection of S.
aureus virulence factors is urgently needed in order
to optimize patient outcomes.
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